ReviewCurrent oncology reports2017
The Role of Surgery for Melanoma in an Era of Effective Systemic Therapy.
Review in Current oncology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Sentinel Node Biopsy for Head and Neck Melanoma: A 12-Year Experience from a Medium-Volume Regional Center.Journal of clinical medicine · 2026Article
- Melanoma of the pleura mimicking malignant mesothelioma: a rare and rapidly progressive pleural disease.BMJ case reports · 2025Article
- Survival nomogram for melanoma with bone metastasis based on the SEER database and an external validation cohort.Frontiers in oncology · 2025Article
- Case Report: A long-term survival case of primary malignant melanoma of the lung with meningeal metastasis.Frontiers in oncology · 2025Article
- Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review.Current oncology reports · 2024Review
- Development of a biomarker signature associated with anoikis to predict prognosis and immunotherapy response in melanoma.Archives of dermatological research · 2024Article
- Combined therapy of dabrafenib and an anti-HER2 antibody-drug conjugate for advanced BRAF-mutant melanoma.Cellular & molecular biology letters · 2024Article
- Advances in the Application of Nanomaterials to the Treatment of Melanoma.Pharmaceutics · 2022Review
- Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Based on Cytolytic Activity in Skin Cutaneous Melanoma.Frontiers in oncology · 2022Article
- A Novel and Effective Method for Human Primary Skin Melanocytes and Metastatic Melanoma Cell Isolation.Cancers · 2021Article
- Pulmonary metastasectomy in the era of targeted therapy and immunotherapy.Journal of thoracic disease · 2021Review
- Clinical characteristics of malignant melanoma in central China and predictors of metastasis.Oncology letters · 2020Article
- Metalloporphyrin Pd(T4) Exhibits Oncolytic Activity and Cumulative Effects with 5-ALA Photodynamic Treatment against C918 Cells.International journal of molecular sciences · 2020Article
- Celastrol Self-Stabilized Nanoparticles for Effective Treatment of Melanoma.International journal of nanomedicine · 2020Article
- The value of metastasectomy in stage IV cutaneous melanoma.Wiener medizinische Wochenschrift (1946) · 2019Review
- Surgery of primary tumor improves the survival of newly diagnosed metastatic melanoma: a population-based, propensity-matched study.Cancer management and research · 2019Article
- Determination of the impact of melanoma surgical timing on survival using the National Cancer Database.Journal of the American Academy of Dermatology · 2018Article
- Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?International journal of molecular sciences · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThe recent discovery of effective systemic treatments for melanoma has dramatically improved the prognosis for patients with advanced disease. As a result, the multidisciplinary management of melanoma has evolved significantly. In the past decades surgery was reserved for symptomatic palliation in patients with metastatic melanoma. Today surgical treatment of patients responding to systemic therapies has become an integral part of disease control. RECENT
findingsCurrent efforts are focused on minimizing the morbidity of surgery (laparoscopic inguinal lymph node dissection, selective completion lymphadenectomy) as well as combining surgery with systemic therapy in novel ways (neoadjuvant targeted and/or immunotherapy, isolated limb infusion/perfusion with systemic immunotherapy). This review examines the use of surgery for advanced melanoma in the era predating modern systemic therapy as well as potential applications moving forward.
Indexed as
Identifiers
28251494What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.